Microfluidics Unveils New Technology Center
PharmacueticalOnline.com
June 29, 2007
Microfluidics, a wholly owned subsidiary of MFIC Corporation, has announced the opening of the Microfluidics Technology Center, a state-of-the-art research and discovery facility. Located at the Microfluidics company headquarters in Newton, Mass., the Center was officially unveiled during the company’s annual shareholders meeting on June 21. Microfluidics President and COO, Bob Bruno, delivered an overview of the company’s rich heritage and provided guests with a scope of what the Center will bring to existing and potential customers in the biotech, pharmaceutical, chemical, personal care and food industries.
“The opening of the Center demonstrates our ongoing commitment to advancing the fluid processing industry and to providing the highest quality of service to our customers,” said Bruno. “While we have always worked closely with customers to solve their most challenging formulation problems, the Microfluidics Technology Center will maximize this experience by providing access to leading R&D engineers and the most advanced equipment in a single-laboratory setting designed specifically with our customers’ unique needs in mind.”
Microfluidics is an industry leader in materials processing and formulation equipment, and possesses the unique ability to produce the most uniform and smallest liquid and suspended structures available for the biotech, pharmaceutical, chemical, personal care and food industries. The Microfluidics Technology Center will provide customers full access to the company’s R&D engineers and complete product suite to prepare, characterize and optimize formulation samples. Engineers will also assist customers in improving existing products through reformulation using proprietary, leading-edge, high-shear Microfluidizer® processors.
“The Microfluidics Technology Center will house our highly-specialized research team, dedicated to advancing the formulation field by developing new applications for Microfluidics’ technology and pursuing groundbreaking work in the field of nanotechnology,” said Dr. Thomai Panagiotou, vice president of research and development.
“We are very excited about the Center and believe it will serve as an innovation hub, playing a critical role in unlocking countless formulation solutions for our customers—including potentially life-saving drugs—that to date could not be formulated.”
Acting Chairman James Little provided Dr. Panagiotou with the keys to the Center and presented founder and former CEO and Chairman, Irwin J. Gruverman, with a plaque commemorating his 25 years of service with the company.
About Microfluidics
Microfluidics, a wholly owned subsidiary of MFIC Corporation, is a supplier of advanced fluid processing equipment and reaction technology for laboratory, pilot scale and manufacturing applications. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products and produces the most uniform and smallest liquid and suspended solid particles available.
Microfluidics has been a worldwide supplier of Microfluidizer® high shear fluid processing systems to the Biotechnology and Pharmaceutical industries since 1984. As leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market.
Companies seeking to produce difficult-to-formulate products or to find better methods of bio-processing can take advantage of complimentary sample testing at one of three Microfluidics facilities. Visit www.microfluidicscorp.com, e-mail <"mailto: mixinginfo@mfics.com">mixinginfo@mfics.com or contact Microfluidics at (800) 370-5452 for application information.
